Cleared Traditional

ABL SYSTEM 625, 615, 605 (K954612) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K954612 · Radiometer America, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1995
Decision
35d
Days
Class 2
Risk

K954612 is an FDA 510(k) clearance for the ABL SYSTEM 625, 615, 605. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Radiometer America, Inc. (Westlake, US). The FDA issued a Cleared decision on November 9, 1995 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Radiometer America, Inc. devices

Submission Details

510(k) Number K954612 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 05, 1995
Decision Date November 09, 1995
Days to Decision 35 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 88d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 47
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K954612.
CIBA CORNING 400 SYSTEM
K961657 · Ciba Corning Diagnostics Corp. · Jun 1996
CIBA CORNING 348 SYSTEM
K962021 · Ciba Corning Diagnostics Corp. · Jun 1996
IL BGGE BLOOD GAS WITH GLUCOSE SYSTEM
K955793 · Instrumentation Laboratory CO · Feb 1996
CIBA CORNING 8-- SERIES CO-OXIMETER
K946206 · Ciba Corning Diagnostics Corp. · Jan 1995
IL1430 BGELECTROLYTE ANALYZER
K935069 · Instrumentation Laboratory CO · Mar 1994
CIBA CORNING 248 PH/BLOOD GAS ANALYZER
K935830 · Ciba Corning Diagnostics Corp. · Feb 1994